AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ... Cancer cell 11 (1), 83-95, 2007 | 2124 | 2007 |
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The lancet oncology 18 (10), 1373-1385, 2017 | 1061 | 2017 |
Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence AD Norden, GS Young, K Setayesh, A Muzikansky, R Klufas, GL Ross, ... Neurology 70 (10), 779-787, 2008 | 1006 | 2008 |
Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ... Journal of Clinical Oncology 28 (17), 2817-2823, 2010 | 578 | 2010 |
Differential sensitivity of glioma-versus lung cancer–specific EGFR mutations to EGFR kinase inhibitors I Vivanco, HI Robins, D Rohle, C Campos, C Grommes, PL Nghiemphu, ... Cancer discovery 2 (5), 458-471, 2012 | 380 | 2012 |
Antiangiogenic therapies for high-grade glioma AD Norden, J Drappatz, PY Wen Nature Reviews Neurology 5 (11), 610-620, 2009 | 332 | 2009 |
Novel anti-angiogenic therapies for malignant gliomas AD Norden, J Drappatz, PY Wen The Lancet Neurology 7 (12), 1152-1160, 2008 | 308 | 2008 |
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma TJ Kaley, P Wen, D Schiff, K Ligon, S Haidar, S Karimi, AB Lassman, ... Neuro-oncology 17 (1), 116-121, 2015 | 292 | 2015 |
Medical management of patients with brain tumors PY Wen, D Schiff, S Kesari, J Drappatz, DC Gigas, L Doherty Journal of neuro-oncology 80, 313-332, 2006 | 229 | 2006 |
Phase I study of GRN1005 in recurrent malignant glioma J Drappatz, A Brenner, ET Wong, A Eichler, D Schiff, MD Groves, ... Clinical Cancer Research 19 (6), 1567-1576, 2013 | 202 | 2013 |
Medical therapies for meningiomas PY Wen, E Quant, J Drappatz, R Beroukhim, AD Norden Journal of neuro-oncology 99, 365-378, 2010 | 201 | 2010 |
Atypical and anaplastic meningiomas treated with bevacizumab L Nayak, FM Iwamoto, JD Rudnick, AD Norden, EQ Lee, J Drappatz, ... Journal of neuro-oncology 109, 187-193, 2012 | 200 | 2012 |
Morphological characteristics of brain tumors causing seizures JW Lee, PY Wen, S Hurwitz, P Black, S Kesari, J Drappatz, AJ Golby, ... Archives of neurology 67 (3), 336-342, 2010 | 195 | 2010 |
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab EC Quant, AD Norden, J Drappatz, A Muzikansky, L Doherty, D LaFrankie, ... Neuro-oncology 11 (5), 550-555, 2009 | 192 | 2009 |
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas L Doherty, DC Gigas, S Kesari, J Drappatz, R Kim, J Zimmerman, ... Neurology 67 (1), 156-158, 2006 | 191 | 2006 |
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08) PY Wen, WKA Yung, KR Lamborn, AD Norden, TF Cloughesy, LE Abrey, ... Neuro-oncology 11 (6), 853-860, 2009 | 190 | 2009 |
Phase II study of protracted daily temozolomide for low-grade gliomas in adults S Kesari, D Schiff, J Drappatz, D LaFrankie, L Doherty, EA Macklin, ... Clinical Cancer Research 15 (1), 330-337, 2009 | 190 | 2009 |
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS FS Hodi, DA Oble, J Drappatz, EF Velazquez, N Ramaiya, ... Nature clinical practice Oncology 5 (9), 557-561, 2008 | 186 | 2008 |
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02 PY Wen, SM Chang, KR Lamborn, JG Kuhn, AD Norden, TF Cloughesy, ... Neuro-oncology 16 (4), 567-578, 2014 | 173 | 2014 |
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma AD Norden, J Drappatz, A Muzikansky, K David, M Gerard, MB McNamara, ... Journal of Neuro-oncology 92, 149-155, 2009 | 161 | 2009 |